Which adverse effect is associated with evinacumab?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Biologic therapies like evinacumab can provoke immune-based reactions because they are proteins that the body may recognize as foreign. Monoclonal antibodies carry a risk of infusion-related hypersensitivity, and severe hypersensitivity reactions (including anaphylaxis) have been observed with their use. This makes severe hypersensitivity the best-matching adverse effect among the given options. Hypertension, dizziness, and nausea are not characteristic adverse effects specifically associated with evinacumab, whereas hypersensitivity is a known concern with monoclonal antibody therapies. If a hypersensitivity reaction occurs, the standard emergency response for anaphylaxis applies (stop infusion, treat with epinephrine, etc.).